MVM has invested in high growth healthcare businesses since 1997. With teams in Boston and London, MVM has a broad, global investment outlook spanning medical technology, pharmaceuticals, diagnostics, contract research and manufacturing, digital health, and other sectors of healthcare.

>$

1

B

AUM

>

100


Collective years investing in healthcare

36


Exits

1997


Founded

Working with MVM

MVM partners with best-in-class management teams to bring innovative products to market, drive growth, make strategic acquisitions, and establish new standards of care in medicine.

We seek out portfolio companies that address significant unmet needs in large addressable markets. These include medical conditions for which there is no adequate treatment, therapies for which existing technologies are too expensive, or diseases for which there is no accurate diagnostic capability, among other situations.

In all of these cases, we prioritize businesses that have a clearly differentiated technology with durable protection against competition, whether through intellectual property, barriers to market entry, statutory exclusivity, or unique branding. After investment, we work closely with management teams to help the business achieve both its near and long term goals.

Work section image

Investment Approach

While MVM does not use fixed investment criteria, we focus on companies that fit the following profile.

Stage

We provide growth equity to commercial-stage businesses. In other words, our investments are intended to accelerate the growth and scale of companies that have commercially available products.

Sector

We invest broadly across healthcare and life sciences. We have made investments in medical devices, pharmaceuticals, diagnostics, digital health, health IT, life science tools, contract research, and contract manufacturing, among other areas. We focus on identifying differentiated products or technologies in each of these categories.

Size

We expect to make aggregate investments of $20 to 100 million in each of our portfolio companies over the life of our holding. In select circumstances, we have the capacity to make larger investments to support unique or creative financing opportunities.

Building image
Door image

Portfolio

MVM invests in innovative healthcare companies. Our active portfolio companies are transforming the delivery of healthcare by enabling higher quality, cost-effective care in large, global markets. We maintain a concentrated portfolio, focused on building world-class companies.

Ossio Logo

Exits

MVM has extensive experience guiding our portfolio companies to successful exits, including both acquisitions and initial public offerings. Selected former portfolio companies include:

City image

Latest news

GT Medical Technologies Names Per Langoe As CEO
February 20, 2024

Full release here: GT Medical Technologies, Inc. Names Per Langoe As CEO

MVM invests in icotec
January 24, 2024

ALTSTAETTEN, Switzerland and EAST HARTFORD, Conn., Jan. 24, 2024 /PR Newswire/ — icotec ag, the leading company in the field of innovative spinal […]

MVM invests in Gynesonics
November 1, 2023

REDWOOD CITY, Calif., Nov. 01, 2023 (GLOBE NEWSWIRE) — Gynesonics® Inc., a women’s healthcare company focused on the development of […]

SkyCell Featured in TechCrunch
October 31, 2023

Full release here: SkyCell raises $57M at a $600M valuation to build smart containers for pharmaceutical transport | TechCrunch

MVM invests in BioProtect
September 27, 2023

TZUR IGAL, Israel, Sept. 27, 2023 /PRNewswire/ — BioProtect Ltd, a private Med Tech company focused on providing innovative, biodegradable spacing solutions, announced today the […]

VitalConnect Secures over $30 Million in Oversubscribed Series F Financing
July 18, 2023

SAN JOSE, Calif.–(BUSINESS WIRE)–VitalConnect®, Inc., a leader in remote and in-hospital wearable biosensor technology, today announced closing on an oversubscribed […]

MVM invests in CurvaFix
July 14, 2023

BELLEVUE, Wash.–(BUSINESS WIRE)–CurvaFix, Inc., a developer of medical devices to repair fractures in curved bones, today announced the close of […]

Vertos Medical Secures $26 Million to Expand Commercialization Efforts and Develop Breakthrough Treatments for Chronic Low Back Pain
June 7, 2023

ALISO VIEJO, Calif., June 7, 2023 /PRNewswire/ — Vertos Medical Inc., a leader in the development of innovative, minimally invasive treatments for […]

eXmoor pharma completes $35 million Series A to expand cell and gene therapy manufacturing capabilities
May 30, 2023

New GMP facility to complete eXmoor’s transition from consultancy to one-stop global cell and gene therapy partner Bristol, UK, May […]

GT Medical Technologies Raises $45 Million in Oversubscribed Series C Financing
March 23, 2023

TEMPE, Ariz., March 23, 2023 /PRNewswire/ — GT Medical Technologies, Inc., a medical device company dedicated to improving the lives of patients […]

Contact Us

info@mvm.com

MVM Partners

Old City Hall

45 School Street

Boston MA 02108

MVM Partners

Fourth Floor

38 Wigmore Street

London W1U 2RU